The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

D-Dopa     (2R)-2-amino-3-(3,4- dihydroxyphenyl)propan...

Synonyms: Dopa D-form, CHEMBL211670, SureCN342665, AG-A-48048, AG-G-04949, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Dopa D-form


Psychiatry related information on Dopa D-form

  • Changes in the activity of dopaminergic neurons associated with intracranial self-stimulation of the ventral tegmentum were assessed by measuring the accumulation of 3,4-dihydroxyphenylalanine (DOPA) after inhibition of aromatic amino acid decarboxylase by NSD-1015 [6].
  • Associated features included marked fatigue, slight facial dysmorphism, short stature, obesity, and learning disability*. Dystonia and fatigue responded to 3,4-dihydroxyphenylalanine (DOPA) therapy, with recurrence of symptoms upon withdrawal; the efficacy has been maintained over 7 years [7].

High impact information on Dopa D-form


Chemical compound and disease context of Dopa D-form


Biological context of Dopa D-form


Anatomical context of Dopa D-form


Associations of Dopa D-form with other chemical compounds


Gene context of Dopa D-form


Analytical, diagnostic and therapeutic context of Dopa D-form


  1. Site-specific replacement of Y356 with 3,4-dihydroxyphenylalanine in the beta2 subunit of E. coli ribonucleotide reductase. Seyedsayamdost, M.R., Stubbe, J. J. Am. Chem. Soc. (2006) [Pubmed]
  2. Interaction of aromatic amino acids in D and L forms with 3,4-dihydroxyphenylalanine decarboxylase from pig kidney. Voltattorni, C.B., Minelli, A., Dominici, P. Biochemistry (1983) [Pubmed]
  3. Concentrations of 3,4-dihydroxyphenylalanine and catecholamines and metabolites in brain in an anhepatic model of hepatic encephalopathy. Hadesman, R., Wiesner, R.H., Go, V.L., Tyce, G.M. J. Neurochem. (1995) [Pubmed]
  4. Are reactive oxygen species involved in the pathogenesis of murine cerebral malaria? Sanni, L.A., Fu, S., Dean, R.T., Bloomfield, G., Stocker, R., Chaudhri, G., Dinauer, M.C., Hunt, N.H. J. Infect. Dis. (1999) [Pubmed]
  5. Low-Na+ medium increases the activity and the phosphorylation of tyrosine hydroxylase in the superior cervical ganglion of the rat. Cahill, A.L., Horwitz, J., Perlman, R.L. J. Neurochem. (1985) [Pubmed]
  6. Increased in vivo tyrosine hydroxylase activity in rat telencephalon produced by self-stimulation of the ventral tegmental area. Phillips, A.G., Jakubovic, A., Fibiger, H.C. Brain Res. (1987) [Pubmed]
  7. DOPA-sensitive dystonia-plus syndrome. Casseron, W., Genton, P. Developmental medicine and child neurology. (2005) [Pubmed]
  8. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. Tsukamoto, K., Jackson, I.J., Urabe, K., Montague, P.M., Hearing, V.J. EMBO J. (1992) [Pubmed]
  9. Novel free radicals in synthetic and natural pheomelanins: distinction between dopa melanins and cysteinyldopa melanins by ESR spectroscopy. Sealy, R.C., Hyde, J.S., Felix, C.C., Menon, I.A., Prota, G., Swartz, H.M., Persad, S., Haberman, H.F. Proc. Natl. Acad. Sci. U.S.A. (1982) [Pubmed]
  10. Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. Nisenbaum, L.K., Zigmond, M.J., Sved, A.F., Abercrombie, E.D. J. Neurosci. (1991) [Pubmed]
  11. Structure-function relationships in the stereospecific and manganese-dependent 3,4-dihydroxyphenylalanine/tyrosine-sulfating activity of human monoamine-form phenol sulfotransferase, SULT1A3. Pai, T.G., Oxendine, I., Sugahara, T., Suiko, M., Sakakibara, Y., Liu, M.C. J. Biol. Chem. (2003) [Pubmed]
  12. Mutation of tyrosine 332 to phenylalanine converts dopa decarboxylase into a decarboxylation-dependent oxidative deaminase. Bertoldi, M., Gonsalvi, M., Contestabile, R., Voltattorni, C.B. J. Biol. Chem. (2002) [Pubmed]
  13. Tryptophan decarboxylase is encoded by two autonomously regulated genes in Camptotheca acuminata which are differentially expressed during development and stress. López-Meyer, M., Nessler, C.L. Plant J. (1997) [Pubmed]
  14. Abnormal 3,4-dihydroxyphenylalanine (dopa) concentrations in plasma and urine of patients with cystic fibrosis. Schöni, M.H., Türler, K., Käser, H., Kraemer, R. Eur. J. Clin. Invest. (1990) [Pubmed]
  15. Formation of melanin-tyrosinase complex and its possible significance as a model for control of melanin synthesis. Menon, I.A., Haberman, H.F. Acta Derm. Venereol. (1978) [Pubmed]
  16. Combined measurements of plasma aromatic L-amino acid decarboxylase and DOPA as tumour markers in diagnosis and follow-up of neuroblastoma. Boomsma, F., Ausema, L., Hakvoort-Cammel, F.G., Oosterom, R., Man in't Veld, A.J., Krenning, E.P., Hahlen, K., Schalekamp, M.A. European journal of cancer & clinical oncology. (1989) [Pubmed]
  17. Photosensitization by antitumor agents 2: anthrapyrazole-photosensitized oxidation of ascorbic acid and 3,4-dihydroxyphenylalanine. Reszka, K., Kolodziejczyk, P., Lown, J.W. Journal of free radicals in biology & medicine. (1986) [Pubmed]
  18. Decarboxylation-dependent transamination catalyzed by mammalian 3,4-dihydroxyphenylalanine decarboxylase. O'Leary, M.H., Baughn, R.L. J. Biol. Chem. (1977) [Pubmed]
  19. Styelin D, an extensively modified antimicrobial peptide from ascidian hemocytes. Taylor, S.W., Craig, A.G., Fischer, W.H., Park, M., Lehrer, R.I. J. Biol. Chem. (2000) [Pubmed]
  20. Regulation of galactokinase gene expression in Tetrahymena thermophila. II. Identification of 3,4-dihydroxyphenylalanine as a primary effector of adrenergic control of galactokinase expression. Ness, J.C., Morse, D.E. J. Biol. Chem. (1985) [Pubmed]
  21. Molecular analysis of a new member of the opium poppy tyrosine/3,4-dihydroxyphenylalanine decarboxylase gene family. Maldonado-Mendoza, I.E., López-Meyer, M., Galef, J.R., Burnett, R.J., Nessler, C.L. Plant Physiol. (1996) [Pubmed]
  22. A transcriptional regulatory element of the gene encoding the 67,000-M(r) form of human glutamate decarboxylase is similar to a Drosophila regulatory element. Erlander, M.G., Tobin, A.J. J. Neurochem. (1992) [Pubmed]
  23. Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes. Bräutigam, M., Kittner, B., Laschinski, G. Mol. Pharmacol. (1985) [Pubmed]
  24. An endogenous cholinergic rhythm may be involved in the circadian changes of tuberoinfundibular dopaminergic neuron activity in ovariectomized rats treated with or without estrogen. Shieh, K.R., Pan, J.T. Endocrinology (1995) [Pubmed]
  25. Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens. Nash, J.F., Meltzer, H.Y., Gudelsky, G.A. J. Neurochem. (1990) [Pubmed]
  26. Phorbol 12,13-dibutyrate increases tyrosine hydroxylase activity in the superior cervical ganglion of the rat. Wang, M., Cahill, A.L., Perlman, R.L. J. Neurochem. (1986) [Pubmed]
  27. Simultaneous determination of 5-hydroxytryptophan and 3,4-dihydroxyphenylalanine in rat brain by HPLC with electrochemical detection following electrical stimulation of the dorsal raphe nucleus. Duda, N.J., Moore, K.E. J. Neurochem. (1985) [Pubmed]
  28. Enantioselectivity of Redox Reaction of DOPA at the Gold Electrode Modified with a Self-Assembled Monolayer of Homocysteine. Nakanishi, T., Matsunaga, M., Nagasaka, M., Asahi, T., Osaka, T. J. Am. Chem. Soc. (2006) [Pubmed]
  29. High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension. Gill, J.R., Grossman, E., Goldstein, D.S. Hypertension (1991) [Pubmed]
  30. The protein oxidation product 3,4-dihydroxyphenylalanine (DOPA) mediates oxidative DNA damage. Morin, B., Davies, M.J., Dean, R.T. Biochem. J. (1998) [Pubmed]
  31. Evidence that mid-lumbar neurones in reflex pathways from group II afferents are involved in locomotion in the cat. Edgley, S.A., Jankowska, E., Shefchyk, S. J. Physiol. (Lond.) (1988) [Pubmed]
  32. 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. Hwang, D.Y., Fleming, S.M., Ardayfio, P., Moran-Gates, T., Kim, H., Tarazi, F.I., Chesselet, M.F., Kim, K.S. J. Neurosci. (2005) [Pubmed]
  33. Stimulatory effect of central oxytocin on tuberoinfundibular dopaminergic neuron activity and inhibition on prolactin secretion: neurochemical and electrophysiological studies. Yuan, Z.F., Pan, J.T. Endocrinology (1996) [Pubmed]
  34. Relationship between phenolamines and catecholamines during rat brain embryonic development in vivo and in vitro. David, J.C. J. Neurochem. (1984) [Pubmed]
  35. Effect of metal ions on the kinetics of tyrosine oxidation catalysed by tyrosinase. Palumbo, A., Misuraca, G., D'Ischia, M., Prota, G. Biochem. J. (1985) [Pubmed]
  36. Cell cycle-dependent modulation of biosynthesis and stimulus-evoked release of catecholamines in PC12 pheochromocytoma cells. Koike, T., Takashima, A. J. Neurochem. (1986) [Pubmed]
  37. Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies? Kish, S.J., Zhong, X.H., Hornykiewicz, O., Haycock, J.W. Ann. Neurol. (1995) [Pubmed]
  38. Regulation of tyrosine hydroxylase activity in rat PC12 cells by neuropeptides of the secretin family. Roskoski, R., White, L., Knowlton, R., Roskoski, L.M. Mol. Pharmacol. (1989) [Pubmed]
  39. In vivo hypothalamic release and synthesis of catecholamines in spontaneously hypertensive rats. Pacák, K., Yadid, G., Jakab, G., Lenders, J.W., Kopin, I.J., Goldstein, D.S. Hypertension (1993) [Pubmed]
  40. Extracellular striatal concentrations of endogenous 3,4-dihydroxyphenylalanine in the absence of a decarboxylase inhibitor: a dynamic index of dopamine synthesis in vivo. Carboni, E., Tanda, G., Di Chiara, G. J. Neurochem. (1992) [Pubmed]
  41. Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats. Westerink, B.H., De Vries, J.B., Duran, R. J. Neurochem. (1990) [Pubmed]
WikiGenes - Universities